Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | PRKCA | P17252 | 5/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27924851 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| SCHEMBL30824648 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| SCHEMBL28218122 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| SCHEMBL181505 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| SCHEMBL3660765 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| SCHEMBL1065817 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| SCHEMBL11417497 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| Cyclohexyl Palmitate SCHEMBL3653509 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| SCHEMBL8736624 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT | |
| Cyclohexyl Heptadecanoate SCHEMBL28217605 | 1.00 | NAAA (1.00) | NAAASMN1; SMN2DGKAEPHX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140227201-A1 | Antimicrobial Gel Formulations | NOVABAY PHARMACEUTICALS, INC. | 2014-08-14 | — | — | US | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| JP-2012500209-A | — | — | 2012-01-05 | — | — | JP | claimed |
| EP-2312939-A1 | ANTIMICROBIAL GEL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. | 2010-03-25 | — | — | US | claimed |
| WO-2010019723-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2010-02-18 | — | — | WO | claimed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| EP-1021511-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | Bush Boake Allen Inc. (US) | 2000-07-26 | — | — | EP | claimed |
| US-5972864-A | BLEACHING BLOCK; MIXTURE OF BLEACH AND ORGANOLEPTIC COMPOUND | LONZA INC. (US) | 1999-10-26 | — | — | US | claimed |
| US-5942153-A | A SHAPED STABLE BLOCK COMPRISING AN ORGANOLEPTIC FRAGRANT AGENT AND BLEACHING AGENT; FRAGRANT AGENT DOES NOT DECOMPOSE THE BLEACHING AGENT, NOT HYGROSCOPIC; USE IN VENTILATING HOOD AS PROTECTIVE GLOVES, A DUST MASK, AND GOGGLES | BUSH BOAKE ALLEN INC. (US) | 1999-08-24 | — | — | US | claimed |
| EP-0622451-B1 | Perfumed hypochlorite bleaching compositions | PROCTER & GAMBLE (US) | 1998-12-02 | — | — | EP | claimed |
| EP-0867503-A2 | Perfumed hypochlorite bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1998-09-30 | — | — | EP | claimed |
| WO-1998006804-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | BUSH BOAKE ALLEN INC. (US) | 1998-02-19 | — | — | WO | claimed |
| US-20260028721-A1 | METHOD FOR MANUFACTURING SUBSTRATE WITH CONDUCTIVE VIAS AND METHOD FOR MANUFACTURING WIRING BOARD WITH CONDUCTIVE VIAS | RESONAC CORP (JP) | 2026-01-29 | — | — | US | disclosed |
| US-20240424614-A1 | METAL PASTE FOR BONDING, AND BONDED BODY AND METHOD FOR PRODUCING SAME | RESONAC CORPORATION (JP) | 2024-12-26 | — | — | US | disclosed |
| EP-4368316-A1 | METAL PASTE FOR BONDING, AND BONDED BODY AND METHOD FOR PRODUCING SAME | Resonac Corporation (JP) | 2024-05-15 | — | — | EP | disclosed |
| EP-0382058-B1 | Process of simultaneously applying multiple layers of hydrophilic colloidal aqueous compositions to a hydrophobic support and multilayer photographic material | MINNESOTA MINING & MFG (US) | 1996-07-31 | — | — | EP | disclosed |
| EP-0622451-A1 | Perfumed hypochlorite bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1994-11-02 | — | — | EP | disclosed |
| US-5188931-A | Highly deionized gelatin, with dispersed droplets of high boiling water immiscible organic solvents; | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-02-23 | — | — | US | disclosed |
| EP-0382058-A2 | Process of simultaneously applying multiple layers of hydrophilic colloidal aqueous compositions to a hydrophobic support and multilayer photographic material | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028721-A1 | METHOD FOR MANUFACTURING SUBSTRATE WITH CONDUCTIVE VIAS AND METHOD FOR MANUFACTURING WIRING BOARD WITH CONDUCTIVE VIAS | PIEZO1, CACNA1C, GJB2 | NAAA 4150/4885SMN1; SMN2 260/4885DGKA 3358/4885 |
| US-20140227201-A1 | Antimicrobial Gel Formulations | CUTA, TUBA3C, POLR1C | NAAA 25/4885SMN1; SMN2 4272/4885DGKA 311/4885 |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | CUTA, TUBA3C, POLR1C | NAAA 25/4885SMN1; SMN2 4272/4885DGKA 311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.